|
BPTF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.669610E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.078200E-01 |
| Normal-vs-Stage2 |
7.708200E-01 |
| Normal-vs-Stage3 |
7.592600E-01 |
| Normal-vs-Stage4 |
8.273000E-01 |
| Stage1-vs-Stage2 |
9.976200E-01 |
| Stage1-vs-Stage3 |
5.335800E-01 |
| Stage1-vs-Stage4 |
6.371200E-01 |
| Stage2-vs-Stage3 |
6.453600E-01 |
| Stage2-vs-Stage4 |
7.157000E-01 |
| Stage3-vs-Stage4 |
9.356000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.615160E-01 |
| Normal-vs-AfricanAmerican |
9.561600E-01 |
| Normal-vs-Asian |
5.698400E-01 |
| Caucasian-vs-AfricanAmerican |
3.652600E-01 |
| Caucasian-vs-Asian |
1.653650E-01 |
| AfricanAmerican-vs-Asian |
5.681000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.909600E-01 |
| Normal-vs-Female |
1.018100E-02 |
| Male-vs-Female |
1.164370E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.304200E-01 |
| Normal-vs-Extreme_Weight |
7.382600E-01 |
| Normal-vs-Obese |
3.758000E-01 |
| Normal-vs-Extreme_Obese |
6.873200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.694400E-01 |
| Normal_Weight-vs-Obese |
6.685000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.545200E-01 |
| Extreme_Weight-vs-Obese |
3.124800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.127000E-01 |
| Obese-vs-Extreme_Obese |
4.209400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.583600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.139930E-02 |
| Normal-vs-Age(61-80Yrs) |
6.837000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.795400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.881000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.838200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.680000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.121000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.706400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.005600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.328100E-02 |
| Normal-VS-Type2 PRCC |
2.754400E-01 |
| Normal-VS-KIRP CIMP |
7.716200E-01 |
| Normal-VS-Unclassified PRCC |
1.263620E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.188030E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.838000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.985400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.995400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.573800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.742580E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.324440E-01 |
| Normal-vs-N1 |
3.446200E-01 |
| Normal-vs-N2 |
7.171000E-01 |
| N0-vs-N1 |
9.289700E-02 |
| N0-vs-N2 |
3.344400E-01 |
| N1-vs-N2 |
9.581800E-01 |
|
|
